Clinical Trial Details
— Status: Recruiting
Administrative data
NCT number |
NCT06316245 |
Other study ID # |
2024/178 |
Secondary ID |
|
Status |
Recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
March 19, 2024 |
Est. completion date |
December 19, 2024 |
Study information
Verified date |
March 2024 |
Source |
Istanbul University |
Contact |
Muserref B Dincer |
Phone |
+905321624712 |
Email |
mberildincer[@]gmail.com |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational [Patient Registry]
|
Clinical Trial Summary
This prospective observational study aims to compare days alive and out of hospital at 30
days (DAOH-30) in patients with poor or good functional capacity undergoing gastrointestinal
surgeries. The investigators are testing the hypothesis that patients with good functional
capacity will have longer days alive and out of hospital than those with poor.
Description:
Days Alive and Out of Hospital (DAOH) is a composite patient-centered outcome that integrates
three critical clinical outcomes: death, hospital length of stay, and hospital readmission.
It is associated with patient comorbidities, surgical complexity, and postoperative
complications.
Evaluation of functional capacity before noncardiac surgery is recommended to identify the
perioperative risks. Duke Activity Status Index (DASI) is one of the tools for determining
functional capacity; the scores are between 0 and 58,2, and high scores are related to
improved capacity. A DASI score of 34 and below was found to be a risk for moderate to severe
complications and new disability.
The primary aim is to compare days alive and out of the hospital at 30 days in patients ≤ 34
and above 34 DASI scores. The secondary aims are to evaluate intensive care unit (ICU) need
and duration, length of hospital stay, rehospitalization, postoperative complications,
morbidity, and mortality in patients with DASI scores ≤ 34 and above 34. Days alive and out
of hospital at 90 days will be compared in both groups as a secondary outcome. The
investigators will also analyze the possible perioperative factors affecting the days alive
and out of the hospital outcome.
Before the operation, the patients will answer the DASI questionnaire in the waiting area of
the operating theatres. The patients will be divided into two groups according to the DASI
score (Poor functional capacity: ≤ 34 points, good functional capacity: above 34 points).
Patient and surgical characteristics (comorbidities, American Society of Anesthesiologists
physical status classification, laboratory values before the operation, frailty index value,
American College of Surgeons Risk Calculator outcomes, surgery type, length of operation,
intraoperative complications), ICU need and duration will be recorded. Postoperative
complications ( cardiovascular, pulmonary, renal, neurologic, surgical, infectious, and wound
), the Postoperative Morbidity Survey (POMS) related morbidity and mortality on the 30th day
will be investigated. Length of hospital stay starting with index surgery, rehospitalization
and duration of further stays will be recorded. Days Alive and Out of Hospital at 30 days
(DAOH-30) will be calculated using mortality, hospital length of stay, and readmissions
between the date of the index surgery and the 30th postoperative day. 90th-day mortality and
Days Alive and Out of Hospital at 90 days (DAOH-90) will also be investigated.